Advertisement
Parsabiv is part of the Calcimimetics class and treats Kidney Disease and Hyperparathyroidism. Calcimimetics are used to treat hyperparathyroidism and kidney disease. They work by lowering levels of the parathyroid hormone in the body. Parsabiv is only available as a brand name drug. Compare calcimimetics.
Advertisement

Parsabiv Latest News

Get the latest updates on this drug from the GoodRx medical team

FDA Approves Parsabiv for Secondary Hyperparathyroidism

The GoodRx Pharmacist - June 28, 2017

In February, manufacturer Amgen announced that the FDA approved Parsabiv (etelcalcetide) for secondary hyperparathyroidism in patients with chronic kidney disease (CKD) on hemodialysis.

Secondary hyperparathyroidism is a condition that lowers calcium levels, causing your parathyroid glands to overproduce the parathyroid hormone. This can cause cardiovascular, neurological and immune system complications. Secondary¬†hyperparathyroidism is especially seen in patients with CKD, but can also be caused by severe vitamin D or calcium deficiency. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.